Both glyco-oxidation parameters, AGE, and pentosidine, correlate with FPG and HbA1c and are elevated only in T2DM patients with and without CHD, and appear to induce greater plaque RAGE expression in diabetic patients with CHD, as previously described in a post-mortem study [29]. This evidence concerns the gene AGER and type 2 diabetes mellitus.